Drug:
Reaction: NEUROPATHY PERIPHERAL
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26507214 |
CA |
2 | |
Neuropathy peripheral, |
||||
OLAPARIB, |
||||
| 302 | 26507382 |
US |
2 | |
Neuropathy peripheral, Discomfort, Back pain, |
||||
| 303 | 26498051 |
US |
62 | 2 |
Neuropathy peripheral, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, CEFTRIAXONE, CEFTRIAXONE SODIUM, EPOETIN ALFA, INSULIN LISPRO, |
||||
| 304 | 26498155 |
CA |
2 | |
Neuropathy peripheral, Condition aggravated, |
||||
LENALIDOMIDE, |
||||
| 305 | 26499199 |
JP |
7 | 1 |
Malignant neoplasm progression, Neuropathy peripheral, |
||||
ZOLBETUXIMAB, OXALIPLATIN, CAPECITABINE, |
||||
| 306 | 26499368 |
US |
64 | 2 |
Neuropathy peripheral, Migraine, Nasal operation, Thyroid disorder, Loss of personal independence in daily activities, Near death experience, Gastrointestinal disorder, |
||||
FREMANEZUMAB-VFRM, |
||||
| 307 | 26499440 |
EU |
63 | 2 |
Neuropathy peripheral, |
||||
ELTROMBOPAG OLAMINE, ELTROMBOPAG, |
||||
| 308 | 26499653 |
2 | ||
Neuropathy peripheral, Dupuytren^s contracture, Condition aggravated, Haematoma, Hypoaesthesia, Drug ineffective, |
||||
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, |
||||
| 309 | 26499757 |
EU |
73 | 1 |
Metastases to lung, Acute kidney injury, Neutropenia, Malignant neoplasm progression, Transitional cell carcinoma recurrent, Haematotoxicity, Neuropathy peripheral, Toxicity to various agents, Neoplasm progression, Neoplasm recurrence, Off label use, Therapy partial responder, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CARBOPLATIN, CARBOPLATIN, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 310 | 26499789 |
US |
76 | |
Neuropathy peripheral, Disease progression, Vertigo, Blister, Drug eruption, |
||||
MOGAMULIZUMAB-KPKC, MOGAMULIZUMAB-KPKC, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 311 | 26499820 |
TH |
81 | 2 |
Neuropathy peripheral, Malignant neoplasm progression, Anaemia, Fatigue, Dry skin, Pruritus, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 312 | 26500319 |
ZA |
2 | |
Aspartate aminotransferase increased, Neuropathy peripheral, Fatigue, |
||||
RITUXIMAB, METHYLPREDNISOLONE, PREDNISONE, AZATHIOPRINE, LEVOTHYROXINE SODIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, PREDNISONE, ROSUVASTATIN, FOLIC ACID, CALCIUM GLUCONATE, |
||||
| 313 | 26500452 |
JP |
36 | 1 |
Neuropathy peripheral, |
||||
METHOTREXATE SODIUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, CYTARABINE, |
||||
| 314 | 26500455 |
JP |
41 | 1 |
Neuropathy peripheral, |
||||
METHOTREXATE SODIUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, |
||||
| 315 | 26500465 |
CA |
75 | 1 |
Asthma, Cardiac failure congestive, Chronic obstructive pulmonary disease, Dyspnoea, Full blood count abnormal, Lung disorder, Muscle spasms, Neuropathy peripheral, Paraesthesia, Pneumonia, Sensory disturbance, Sleep disorder due to a general medical condition, Sputum discoloured, Tachycardia, Therapeutic product effect incomplete, Therapeutic response shortened, Wheezing, |
||||
TIOTROPIUM BROMIDE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, MONTELUKAST, MONTELUKAST, GLYCOPYRROLATE, BUDESONIDE, BUPRENORPHINE, ROFLUMILAST, DEXLANSOPRAZOLE, DUPILUMAB, MEPOLIZUMAB, MEPOLIZUMAB, PREDNISONE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CALCIUM CARBONATE, MOXIFLOXACIN HYDROCHLORIDE, MOMETASONE FUROATE, MOMETASONE, PREGABALIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, OMALIZUMAB, BENRALIZUMAB, GABAPENTIN ENACARBIL, MEPOLIZUMAB, |
||||
| 316 | 26500645 |
JP |
||
Death, Neuropathy peripheral, Eye disorder, Nausea, Malaise, Dizziness, |
||||
ENCORAFENIB, |
||||
| 317 | 26501142 |
US |
57 | 2 |
JC virus infection, Neuropathy peripheral, Disability, Migraine, Product use in unapproved indication, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 318 | 26501237 |
US |
||
Neuropathy peripheral, Off label use, |
||||
LENALIDOMIDE, |
||||
| 319 | 26501439 |
EU |
75 | 2 |
Neuropathy peripheral, Vitamin B12 deficiency, |
||||
PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 320 | 26501508 |
US |
75 | 2 |
Constipation, Neuropathy peripheral, Urinary tract infection, |
||||
POMALIDOMIDE, ACYCLOVIR, ALBUTEROL SULFATE, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUPROPION HYDROCHLORIDE, CEPHALEXIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, GABAPENTIN, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, MINOCYCLINE HYDROCHLORIDE, TRIMETHOPRIM, ERGOCALCIFEROL, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 321 | 26501631 |
US |
||
Neuropathy peripheral, Pain, Arthralgia, Pain in extremity, Dyskinesia, Product packaging difficult to open, Product quality issue, Nausea, Cough, Headache, Hypotension, Dizziness, Chest pain, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, VITAMIN C, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, ALBUTEROL SULFATE, CALCIUM, OXYGEN, 0XYGEN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, WARFARIN SODIUM, WARFARIN, |
||||
| 322 | 26501682 |
EU |
79 | 1 |
Polyarthritis, Neuropathy peripheral, |
||||
PEMBROLIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FUROSEMIDE, ENFORTUMAB VEDOTIN, |
||||
| 323 | 26501848 |
EU |
79 | 1 |
Hypoaesthesia, Neuropathy peripheral, |
||||
ENZALUTAMIDE, ENZALUTAMIDE, |
||||
| 324 | 26502077 |
JP |
||
Hypokalaemia, Hyperkalaemia, Neuropathy peripheral, Neutropenia, Delirium, Stomatitis, Nausea, Vomiting, Diarrhoea, Hypotension, Hypercalcaemia, Hepatic function abnormal, Somnolence, Constipation, Hypermagnesaemia, Renal disorder, Hypertension, Haemorrhage, International normalised ratio increased, Platelet count decreased, Hypoglycaemia, Palmar-plantar erythrodysaesthesia syndrome, Rash, Hyperglycaemia, Blood creatine phosphokinase increased, Bradycardia, Hyponatraemia, Hypernatraemia, Vascular pain, Adverse event, |
||||
BEVACIZUMAB, |
||||
| 325 | 26502376 |
US |
||
Neuropathy peripheral, Hypokalaemia, Hypertension, Diarrhoea, |
||||
RUXOLITINIB, |
||||
| 326 | 26502643 |
64 | 2 | |
Neuropathy peripheral, Skin fissures, Platelet count decreased, Off label use, |
||||
CETUXIMAB, |
||||
| 327 | 26502684 |
EU |
65 | 2 |
Neuropathy peripheral, Off label use, Intentional product use issue, |
||||
DEXAMETHASONE SODIUM PHOSPHATE, LENALIDOMIDE, MELPHALAN HYDROCHLORIDE, MELPHALAN, BORTEZOMIB, |
||||
| 328 | 26497885 |
GB |
2 | |
Neuropathy peripheral, Fatigue, |
||||
OLAPARIB, |
||||
| 329 | 26496773 |
EU |
62 | 1 |
Neuropathy peripheral, Dermatitis acneiform, Therapy partial responder, |
||||
PANITUMUMAB, PANITUMUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, |
||||
| 330 | 26496896 |
US |
63 | 1 |
Tremor, Visual impairment, Neuropathy peripheral, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN ASPART, INSULIN GLARGINE, |
||||
| 331 | 26492031 |
EU |
2 | |
Neuropathy peripheral, |
||||
MIRVETUXIMAB SORAVTANSINE, MIRVETUXIMAB SORAVTANSINE, |
||||
| 332 | 26492073 |
US |
1 | |
Neuropathy peripheral, Pain in extremity, Erythema, Peripheral swelling, |
||||
ADALIMUMAB, |
||||
| 333 | 26492330 |
US |
53 | 1 |
Neuropathy peripheral, White matter lesion, |
||||
PASIREOTIDE, PASIREOTIDE, DULOXETINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUSPIRONE HYDROCHLORIDE, CARVEDILOL, TADALAFIL, DEXLANSOPRAZOLE, LISINOPRIL, MITOMYCIN, INSULIN ASPART, LANSOPRAZOLE, TORSEMIDE, INSULIN GLARGINE, ERGOCALCIFEROL, |
||||
| 334 | 26492578 |
CA |
62 | 2 |
Constipation, Fatigue, Insomnia, Neuropathy peripheral, Pain, Rash, Treatment delayed, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 335 | 26493094 |
EU |
61 | 1 |
Decreased appetite, Allodynia, Confusional state, Constipation, Quality of life decreased, Chronic kidney disease, Dermatitis allergic, Polyneuropathy in malignant disease, Polyneuropathy, Drug dependence, Hyperaesthesia, Metastases to lung, Anaemia, Metastases to bone, Toxicity to various agents, Prostate cancer, Malignant neoplasm progression, Neuropathy peripheral, Pain, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, KETOPROFEN, KETOPROFEN, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, MORPHINE SULFATE, BICALUTAMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, DENOSUMAB, TAPENTADOL HYDROCHLORIDE, TAPENTADOL HYDROCHLORIDE, TAPENTADOL HYDROCHLORIDE, TAPENTADOL HYDROCHLORIDE, TAPENTADOL HYDROCHLORIDE, TAPENTADOL HYDROCHLORIDE, TAPENTADOL HYDROCHLORIDE, PREGABALIN, PREGABALIN, PREGABALIN, ABIRATERONE ACETATE, ABIRATERONE, IRON, MORPHINE SULFATE, MORPHINE SULFATE, ERGOCALCIFEROL, |
||||
| 336 | 26493412 |
US |
||
Cytokine release syndrome, Hypovolaemia, Syncope, Neuropathy peripheral, Diarrhoea, Pyrexia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, CARBOPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYCODONE, |
||||
| 337 | 26493418 |
EU |
||
Death, Concomitant disease aggravated, Disease recurrence, Nail disorder, Haematotoxicity, Disease progression, Diarrhoea, Fatigue, Alopecia, Neuropathy peripheral, Breast cancer metastatic, Asthenia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, FULVESTRANT, FULVESTRANT, GOSERELIN, GOSERELIN, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 338 | 26493957 |
US |
72 | 2 |
White blood cell count abnormal, Neuropathy peripheral, |
||||
LENALIDOMIDE, |
||||
| 339 | 26493991 |
JP |
7 | |
Triple negative breast cancer, Neuropathy peripheral, Diarrhoea, Malaise, Stomatitis, Decreased appetite, White blood cell disorder, Anaemia, |
||||
SACITUZUMAB GOVITECAN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 340 | 26494286 |
US |
2 | |
Neuropathy peripheral, Hypotension, Dizziness, |
||||
OSIMERTINIB, |
||||
| 341 | 26494542 |
US |
2 | |
Neuropathy peripheral, Fatigue, |
||||
OLAPARIB, AMOXICILLIN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, MAGNESIUM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ERGOCALCIFEROL, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 342 | 26494602 |
EU |
68 | 1 |
Neuropathy peripheral, Transaminases increased, Product use issue, |
||||
PREDNISONE, PREDNISONE, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FILGRASTIM, FILGRASTIM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 343 | 26494687 |
CN |
||
Neuropathy peripheral, Infection, Intestinal obstruction, Cardiac failure, Respiratory failure, Vision blurred, Photophobia, Xerophthalmia, Gastrointestinal toxicity, Hepatic enzyme increased, |
||||
BEVACIZUMAB, MIRVETUXIMAB SORAVTANSINE, |
||||
| 344 | 26494792 |
EU |
60 | 2 |
Neuropathy peripheral, Off label use, |
||||
RITUXIMAB, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 345 | 26494794 |
JP |
26 | 1 |
Neuropathy peripheral, Arthralgia, |
||||
GEMCITABINE HYDROCHLORIDE, METHOTREXATE SODIUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), OXALIPLATIN, |
||||
| 346 | 26494798 |
EU |
62 | 2 |
Tendonitis, Neuropathy peripheral, Periarthritis, Diarrhoea, Anal spasm, Insomnia, Anxiety, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AMOXICILLIN, |
||||
| 347 | 26494858 |
US |
2 | |
Neuropathy peripheral, Malaise, Nausea, Fatigue, Pain, Central venous catheterisation, |
||||
OLAPARIB, BEVACIZUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CLOPIDOGREL, CLOPIDOGREL BISULFATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ERGOCALCIFEROL, POLYETHYLENE GLYCOL 3350, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, |
||||
| 348 | 26495235 |
78 | ||
Neuropathy peripheral, Pruritus, Injection site bruising, |
||||
ZILUCOPLAN, CALCIUM, OXYBUTYNIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 349 | 26495295 |
IL |
48 | 1 |
Neuropathy peripheral, Pruritus, Rash, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 350 | 26495425 |
US |
||
Pneumonia, Neuropathy peripheral, Cerebral disorder, Skin weeping, Dry skin, Fatigue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 351 | 26495445 |
US |
2 | |
Lung neoplasm malignant, Neuropathy peripheral, Dizziness, Inner ear disorder, |
||||
DURVALUMAB, |
||||
| 352 | 26495695 |
US |
75 | 2 |
Neuropathy peripheral, Alopecia, Dry skin, Skin exfoliation, Chapped lips, Fatigue, Diarrhoea, Cough, Arthritis, Apathy, |
||||
PALBOCICLIB, PALBOCICLIB, |
||||
| 353 | 26495774 |
GB |
66 | 1 |
Depression, Neuropathy peripheral, |
||||
TRIPTORELIN, |
||||
| 354 | 26496226 |
US |
1 | |
Acute respiratory failure, Neuropathy peripheral, Dyspnoea, |
||||
OSIMERTINIB, |
||||
| 355 | 26496561 |
EU |
43 | 2 |
Neuropathy peripheral, |
||||
PEMBROLIZUMAB, |
||||
| 356 | 26500478 |
2 | ||
Fall, Neuropathy peripheral, |
||||
| 357 | 26486470 |
JP |
2 | |
Neuropathy peripheral, |
||||
OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, BEVACIZUMAB, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 358 | 26487424 |
GB |
54 | 1 |
Brain fog, Neuropathy peripheral, Fatigue, Dyspnoea, Diarrhoea, Dry skin, Abdominal pain upper, |
||||
DENOSUMAB, BEVACIZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXALIPLATIN, |
||||
| 359 | 26488049 |
US |
1 | |
Neuropathy peripheral, |
||||
ACALABRUTINIB, AMOXICILLIN, VALSARTAN, VALSARTAN ORAL, FINASTERIDE, |
||||
| 360 | 26488110 |
75 | 1 | |
Neuropathy peripheral, |
||||
LENALIDOMIDE, |
||||
| 361 | 26488292 |
GB |
54 | 1 |
Neuropathy peripheral, Brain fog, Fatigue, Dyspnoea, Diarrhoea, Dry skin, Abdominal pain upper, |
||||
DENOSUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BEVACIZUMAB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXALIPLATIN, |
||||
| 362 | 26488362 |
US |
2 | |
Neuropathy peripheral, Diarrhoea, Fatigue, Muscle spasms, Swelling, Flatulence, Anxiety, Depression, Dysphagia, |
||||
OLAPARIB, |
||||
| 363 | 26489155 |
JP |
1 | |
Neuropathy peripheral, Rash, Paronychia, |
||||
OSIMERTINIB, |
||||
| 364 | 26489292 |
IN |
58 | 1 |
Sarcopenia, Neuropathy peripheral, Hyperkalaemia, Impaired gastric emptying, Encephalopathy, Cytomegalovirus viraemia, Acute kidney injury, Stenotrophomonas sepsis, Candida sepsis, Thrombocytopenia, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHYLPREDNISOLONE, |
||||
| 365 | 26489355 |
US |
66 | 2 |
COVID-19, H1N1 influenza, Pneumonia, Neuropathy peripheral, |
||||
LENALIDOMIDE, |
||||
| 366 | 26489484 |
GB |
72 | 2 |
Neuropathy peripheral, Hypoaesthesia, |
||||
| 367 | 26490052 |
EU |
62 | 1 |
Condition aggravated, Memory impairment, Confusional state, Dizziness, Neuropathy peripheral, Urinary incontinence, Motor dysfunction, Coordination abnormal, Off label use, |
||||
LORLATINIB, |
||||
| 368 | 26490110 |
GB |
55 | 2 |
Neuropathy peripheral, Skin exfoliation, Diarrhoea, Fatigue, Asthenia, Erythema, Feeling hot, |
||||
BEVACIZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXALIPLATIN, CAPECITABINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 369 | 26490114 |
US |
66 | |
Neuropathy peripheral, Off label use, |
||||
RUXOLITINIB, TOLTERODINE TARTRATE, FAMOTIDINE, GABAPENTIN, GLYCOPYRROLATE, |
||||
| 370 | 26490401 |
US |
2 | |
Neuropathy peripheral, Headache, Epistaxis, Pyrexia, |
||||
DABRAFENIB, TRAMETINIB, CAPECITABINE, |
||||
| 371 | 26490607 |
US |
67 | 1 |
Nausea, Neuropathy peripheral, |
||||
POMALIDOMIDE, |
||||
| 372 | 26490726 |
US |
81 | |
Chronic kidney disease, Atrial fibrillation, Extradural haematoma, Hemiparesis, Shock haemorrhagic, Gastrointestinal haemorrhage, Neuropathy peripheral, Arrhythmia, Balance disorder, Asthenia, Hepatic enzyme increased, Anaemia, Haemorrhage, Spinal cord disorder, Malnutrition, Depression, Liver function test increased, Deep tissue injury, Pyuria, Urinary tract infection, Troponin increased, Hypertransaminasaemia, |
||||
ABATACEPT, ALLOPURINOL, ASCORBIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DUTASTERIDE, EMPAGLIFLOZIN, ERGOCALCIFEROL, EZETIMIBE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MIRTAZAPINE, NITROGLYCERIN, PANTOPRAZOLE, ROSUVASTATIN, SERTRALINE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, VALSARTAN, VALSARTAN ORAL, VITAMIN A, VITAMIN E, VITAMIN C, |
||||
| 373 | 26490800 |
JP |
66 | 1 |
Neuropathy peripheral, Malignant neoplasm progression, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, OXALIPLATIN, |
||||
| 374 | 26490997 |
US |
59 | 2 |
Photophobia, Neuropathy peripheral, Fatigue, |
||||
ABEMACICLIB, |
||||
| 375 | 26491335 |
78 | 1 | |
Bronchiolitis, Neuropathy peripheral, Malignant neoplasm progression, |
||||
CETUXIMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, OXALIPLATIN, |
||||
| 376 | 26491379 |
US |
69 | 2 |
Conjunctival haemorrhage, Neuropathy peripheral, Gait inability, Lacrimation increased, Dyspnoea, Nausea, Platelet count decreased, Fatigue, Asthenia, Inappropriate schedule of product administration, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, |
||||
| 377 | 26491394 |
US |
63 | 1 |
Generalised oedema, Neuropathy peripheral, Demyelination, Blood albumin decreased, Protein total decreased, |
||||
ZONGERTINIB, |
||||
| 378 | 26491438 |
GB |
2 | |
Neuropathy peripheral, Fatigue, Diarrhoea, Localised infection, |
||||
PEMBROLIZUMAB, |
||||
| 379 | 26491674 |
EU |
75 | 1 |
Immune-mediated pancreatitis, Troponin increased, Dyspnoea, Neuropathy peripheral, Asthenia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 380 | 26493679 |
89 | 2 | |
Neuropathy peripheral, Therapy cessation, |
||||
POMALIDOMIDE, |
||||
| 381 | 26480907 |
US |
||
Syncope, Neuropathy peripheral, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, LEVOCETIRIZINE DIHYDROCHLORIDE, PYRIDOSTIGMINE BROMIDE, FAMOTIDINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, KETOTIFEN FUMARATE, BUDESONIDE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VARENICLINE, VORTIOXETINE, CYCLOSPORINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVALBUTEROL TARTRATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MEPOLIZUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 382 | 26481007 |
US |
66 | 2 |
White blood cell count decreased, Neuropathy peripheral, |
||||
POMALIDOMIDE, |
||||
| 383 | 26481364 |
GB |
42 | |
Neuropathy peripheral, |
||||
USTEKINUMAB, USTEKINUMAB, MIRTAZAPINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 384 | 26481419 |
US |
2 | |
Dyskinesia, Urinary retention, Groin pain, Pain in extremity, Discomfort, Neuropathy peripheral, |
||||
ADALIMUMAB, HYDROXYCHLOROQUINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, AMLODIPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, METHOCARBAMOL, METHOCARBAMOL TABLETS, ALPRAZOLAM, PREDNISONE, ZONISAMIDE, |
||||
| 385 | 26481813 |
US |
83 | 2 |
Neuropathy peripheral, Deep vein thrombosis, Fatigue, White blood cell count decreased, Red blood cell count decreased, Chromaturia, Pulmonary mass, Cough, Haematuria, |
||||
OLAPARIB, AMITRIPTYLINE HYDROCHLORIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CYCLOSPORINE, SIMVASTATIN, |
||||
| 386 | 26482875 |
US |
61 | 2 |
Neuropathy peripheral, Product prescribing issue, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, ISONIAZID, ISONIAZID, ISONIAZID, ISONIAZID, |
||||
| 387 | 26483067 |
US |
2 | |
Neuropathy peripheral, |
||||
TREPROSTINIL, TREPROSTINIL, SEMAGLUTIDE, ORAL SEMAGLUTIDE, CALCIUM, ERGOCALCIFEROL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ARIPIPRAZOLE, MORPHINE SULFATE, DOXYLAMINE SUCCINATE, ATORVASTATIN CALCIUM, POLYETHYLENE GLYCOL 3350, SILDENAFIL CITRATE, SILDENAFIL, AMITRIPTYLINE HYDROCHLORIDE, OXYGEN, 0XYGEN, SPIRONOLACTONE, BUSPIRONE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, FUROSEMIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, DULOXETINE HYDROCHLORIDE, DULOXETINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FLUCONAZOLE, ONDANSETRON HYDROCHLORIDE, AMBRISENTAN, |
||||
| 388 | 26483229 |
EU |
75 | 2 |
Neuropathy peripheral, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 389 | 26483676 |
US |
52 | 2 |
Neuropathy peripheral, Rash, |
||||
ENCORAFENIB, |
||||
| 390 | 26483747 |
GB |
80 | 2 |
Infection, Diarrhoea, Fatigue, Neuropathy peripheral, |
||||
PEMBROLIZUMAB, |
||||
| 391 | 26483873 |
US |
||
Neuropathy peripheral, |
||||
EVOLOCUMAB, |
||||
| 392 | 26484181 |
US |
2 | |
Neuropathy peripheral, Arthritis, Product use complaint, |
||||
RIBOCICLIB, |
||||
| 393 | 26484569 |
EU |
76 | 1 |
Neuropathy peripheral, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 394 | 26484687 |
US |
67 | 1 |
Metastases to skin, Fatigue, Neuropathy peripheral, |
||||
LENALIDOMIDE, |
||||
| 395 | 26485817 |
52 | 2 | |
Neuropathy peripheral, Hypothyroidism, Pain, Feeling abnormal, Pain in extremity, Pain in extremity, Headache, Decreased appetite, Gait inability, Movement disorder, Weight decreased, Adrenocortical insufficiency acute, Hypocalcaemia, Delirium, Asthenia, Pain in extremity, Impaired work ability, Muscle spasms, Fatigue, Product complaint, |
||||
PEMBROLIZUMAB, |
||||
| 396 | 26476067 |
US |
58 | 1 |
Neuropathy peripheral, Oral discomfort, Fatigue, Hypertension, Stomatitis, |
||||
FRUQUINTINIB, FRUQUINTINIB, AMOXICILLIN, BUPROPION, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, MELATONIN, PREDNISONE, PROCHLORPERAZINE, |
||||
| 397 | 26476081 |
EU |
2 | |
Malignant neoplasm progression, Neuropathy peripheral, Metastases to pleura, Metastases to retroperitoneum, Metastases to peritoneum, |
||||
BEVACIZUMAB, OLAPARIB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 398 | 26476133 |
US |
76 | 2 |
Neuropathy peripheral, Fatigue, Blood glucose increased, Globulins decreased, Vitamin B6 decreased, |
||||
ASFOTASE ALFA, |
||||
| 399 | 26476140 |
EU |
43 | 2 |
Stevens-Johnson syndrome, Neuropathy peripheral, |
||||
HYDROXYCHLOROQUINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 400 | 26476276 |
US |
77 | 1 |
Neuropathy peripheral, |
||||
THALIDOMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28